Crossmark

Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system

Crossref DOI link: https://doi.org/10.1186/s12885-020-07624-4

Published Online: 2020-11-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Xuyao

Wang, Yuwen

Yuan, Zhiyong

Yu, Hui

Song, Yongchun

Zhao, Lujun

Wang, Ping
Funding

Funding for this research was provided by:

Postdoctoral Research Foundation of China (2019M661039)

ianjin Medical University Cancer Institute and Hospital (1903)
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 18 December 2019

Accepted: 10 November 2020

First Online: 25 November 2020

Ethics approval and consent to participate

: Patients gave verbal informed consent to participate at time of diagnosis and the ethics committee at Tianjin Tumor Hospital approved this procedure (Ek2019037). Patients were informed that they had the opportunity to opt-out if they were not willing to participate in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below